StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Morgan Stanley Reiterates Overweight Rating on CVS Health (CVS)
October 2, 2024 6:56 AM
Morgan Stanley analyst Erin Wright reiterated an Overweight rating and $65.00 price target on CVS Health (NYSE: CVS).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Comments
Next Articles
TD Cowen Upgrades CVS Health (CVS) to Buy
October 4, 2024 5:30 AM
Mizuho Reiterates Outperform Rating on CVS Health (CVS)
October 2, 2024 6:51 AM
CVS Health to lay off nearly 2,900 employees in cost-cutting push
October 1, 2024 12:43 PM
Health insurers unveil Medicare Advantage plans for 2025
October 1, 2024 8:04 AM
Aetna 2025 Medicare plans focus on most important health needs for members
October 1, 2024 8:00 AM
Leerink Partners Reiterates Market Perform Rating on CVS Health (CVS)
October 1, 2024 6:28 AM
Evercore ISI Reiterates Outperform Rating on CVS Health (CVS)
October 1, 2024 5:54 AM
CVS Health mulling options, including possible break-up - Reuters
October 1, 2024 4:47 AM
CVS explores options including potential break-up, sources say
September 30, 2024 7:02 PM
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.04%
September 30, 2024 5:05 PM
Glenview Capital to push CVS Health to make changes - Wall Street Journal
September 30, 2024 8:50 AM
Glenview Capital Prepares for Activist Push at CVS Health (CVS) - WSJ (earlier)
September 30, 2024 7:17 AM
